This is an inhibitory receptor expressed on lymphocytes that interacts with its complementary target, CD155 (Polio Virus Receptors, PVR or NECL-5) on the surface of antigen-presenting cells or tumour cells to suppress T and natural killer (NK) cell anti-tumour responses [5]. This evidence concerns the gene PVR and neoplasm.